That may be why NUSAP1 was elevated in NAFLD patients with liver fibrosis, where the capacity of regeneration of the liver by compensatory proliferation is dramatically reduced. This evidence concerns the gene NUSAP1 and metabolic dysfunction-associated steatotic liver disease.